house · trading 2012-04-24 → 2018-12-13
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2017-12-11 | UNM | SELL | $1K–$15K | $56.65 | $89.41 2026-07-13 | +68.4% rt |
| 2017-12-11 | UNM | BUY | $1K–$15K | $56.65 | $89.41 2026-07-13 | +57.8% |
| 2017-12-11 | PM | SELL | $1K–$15K | $106.04 | $180.19 2026-07-13 | +31.9% rt |
| 2017-12-11 | PM | BUY | $1K–$15K | $106.04 | $180.19 2026-07-13 | +69.9% |
| 2017-12-07 | SAFRY | BUY | $1K–$15K | $26.38 | $93.30 2026-07-13 | +253.7% |
| 2017-12-07 | ABBNY | BUY | $1K–$15K | $24.77 | $101.61 2026-07-13 | +310.2% |
| 2017-11-30 | CNI | BUY | $1K–$15K | $77.98 | $125.31 2026-07-13 | +60.7% |
| 2017-11-30 | ASBPF | BUY | $1K–$15K | — | — | — |
| 2017-11-29 | VNDX | BUY | $1K–$15K | — | — | — |
| 2017-11-29 | T | BUY | $1K–$15K | $27.55 | $21.55 2026-07-13 | -21.8% |
| 2017-11-29 | RYAAY | BUY | $1K–$15K | $50.70 | $63.91 2026-07-13 | +26.1% |
| 2017-11-29 | MDSO | BUY | $1K–$15K | — | — | — |
| 2017-11-29 | GMED | BUY | $1K–$15K | $38.50 | $79.75 2026-07-13 | +107.1% |
| 2017-11-29 | CNI | BUY | $1K–$15K | $76.36 | $125.31 2026-07-13 | +64.1% |
| 2017-11-29 | COMP | BUY | $1K–$15K | $20.68 | $32.86 2026-06-26 | +58.9% |
| 2017-11-28 | PEN | BUY | $1K–$15K | $105.60 | $318.94 2026-07-13 | +202.0% |
| 2017-11-27 | TCEHY | BUY | $1K–$15K | $53.00 | $58.01 2026-07-13 | +9.4% |
| 2017-11-27 | SUPN | BUY | $1K–$15K | $38.90 | $47.35 2026-07-13 | +21.7% |
| 2017-11-27 | KO | BUY | $1K–$15K | $45.90 | $84.25 2026-07-13 | +83.5% |
| 2017-11-27 | AMSF | BUY | $1K–$15K | $64.70 | $35.29 2026-07-13 | -45.5% |
| 2017-11-21 | DPAGY | BUY | $1K–$15K | — | — | — |
| 2017-11-20 | CORT | BUY | $1K–$15K | $17.09 | $85.90 2026-07-13 | +402.6% |
| 2017-11-20 | BMCVY | BUY | $1K–$15K | — | — | — |
| 2017-11-17 | RDS.A | BUY | $1K–$15K | — | — | — |
| 2017-11-17 | RDEV | BUY | $1K–$15K | — | — | — |
| 2017-11-17 | NVS | BUY | $1K–$15K | $75.25 | $153.37 2026-07-13 | +103.8% |
| 2017-11-17 | MOT | BUY | $1K–$15K | — | — | — |
| 2017-11-17 | IBN | BUY | $1K–$15K | $9.89 | $29.26 2026-07-13 | +195.8% |
| 2017-11-17 | CLOV | BUY | $1K–$15K | — | — | — |
| 2017-11-17 | BSEY | BUY | $15K–$50K | — | — | — |
| 2017-11-17 | BNCOV | BUY | $1K–$15K | — | — | — |
| 2017-11-15 | ABMD | SELL | $15K–$50K | — | — | — exit |
| 2017-11-13 | GSK | BUY | $1K–$15K | $35.09 | $52.29 2026-07-13 | +49.0% |
| 2017-11-10 | GSK | BUY | $1K–$15K | $35.30 | $52.29 2026-07-13 | +48.1% |
| 2017-11-09 | GIS | BUY | $1K–$15K | $51.78 | $36.60 2026-07-13 | -29.3% |
| 2017-11-03 | SAGE | BUY | $1K–$15K | — | — | — |
| 2017-11-03 | GXP | BUY | $1K–$15K | $33.28 | $31.99 2018-06-04 | -3.9% |
| 2017-11-02 | GXP | BUY | $1K–$15K | $32.82 | $31.99 2018-06-04 | -2.5% |
| 2017-11-02 | EGBN | BUY | $1K–$15K | $67.10 | $26.89 2026-07-13 | -59.9% |
| 2017-11-01 | MRSH | BUY | $50K–$100K | $82.42 | $181.53 2026-07-13 | +120.3% |
| 2017-11-01 | MA | BUY | $15K–$50K | $148.89 | $537.70 2026-07-13 | +261.1% |
| 2017-11-01 | GXP | BUY | $1K–$15K | $32.49 | $31.99 2018-06-04 | -1.5% |
| 2017-11-01 | FISV | BUY | $1K–$15K | $62.76 | $51.18 2026-07-13 | -18.4% |
| 2017-11-01 | EGBN | BUY | $1K–$15K | $66.25 | $26.89 2026-07-13 | -59.4% |
| 2017-10-30 | NLSN | SELL | $1K–$15K | — | — | — exit |
| 2017-10-30 | NLSN | BUY | $1K–$15K | — | — | — |
| 2017-10-30 | MSFT | SELL | $1K–$15K | $83.89 | $390.99 2026-07-13 | +69.8% rt |
| 2017-10-30 | MSFT | BUY | $1K–$15K | $83.89 | $390.99 2026-07-13 | +366.1% |
| 2017-10-30 | CCI | BUY | $1K–$15K | $106.11 | $79.84 2026-07-13 | -24.8% |
| 2017-10-27 | NLSN | SELL | $1K–$15K | — | — | — exit |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Josh Gottheimer | 125 · AMAT, COST, CVX, DLTR, FCX, GD |
| SUSAN M COLLINS | 106 · APC, BAC, BMY, C, CVX, ESRX |
| Thomas H Tuberville | 102 · AMAT, BMY, CSX, CVX, FCX, GD |
| Sheldon Whitehouse | 97 · BAC, BMY, COST, C, CSX, ESRX |
| Lois Frankel | 96 · AMAT, APC, C, ESRX, GD, JPM |
| Gilbert Cisneros | 92 · AMAT, BMY, COST, JPM, MU, PFE |
| Rohit Khanna | 92 · AMAT, BAC, C, JPM, MET, MS |
| K. Michael Conaway | 85 · BAC, BMY, COST, CVX, DLTR, ESRX |
| Thomas R Tillis | 83 · BECN, CRZO, CTCT, MDCA, PBH, TUMI |
| Shelley M Capito | 81 · BMY, COST, C, CSX, CVX, GD |
| Alan S. Lowenthal | 80 · BAC, BMY, COST, C, ESRX, GD |
| John A. Yarmuth | 80 · BAC, BMY, COST, C, CSX, CVX |